IVF-ART ApS: Financial statements 2023
CVR: 41526610
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
IVF-ART ApS (CVR 41526610) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -8,921 and a net result of DKK -151,218 compared with DKK -8,105,992 the year before. Equity in the 2023 report amounted to DKK 1,174,786. The solvency ratio was 99.4%.
- Gross Profit
- DKK -8,921
- Profit/Loss
- DKK -151,218
- Equity
- DKK 1,174,786
- Total Assets
- DKK 1,182,286
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | -9 t. | -151 t. | 1.2 mio. | - |
| 2022 | - | -9 t. | -8.1 mio. | 1.3 mio. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
IVF-ART ApS has published its annual report for 2022. Gross profit came to DKK -8,920, and the net result was DKK -8,105,992.
About IVF-ART ApS
IVF-ART ApS is a Danish company of the type Anpartsselskab based in Holte, founded in 2020. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Hans Kristen Krog and Ursula Bentin-Ley. The company is owned by Ursula Bentin-Ley. According to the 2025 annual report, the company had an average of 2 employees. In 2025, the company reported a gross profit of DKK -7,500 and a net result of DKK -7,500 compared with DKK -8,545 the year before. Equity in the 2025 report amounted to DKK 508,741.